기도 관리 기기 시장 : 제품 유형, 재료, 삽입 방법, 최종 사용자, 용도, 사이즈별 예측(2026-2032년)

The Airway Management Devices Market is projected to grow by USD 3.63 billion at a CAGR of 8.19% by 2032.

Airway management devices are central to safe ventilation, oxygenation, anesthesia delivery, resuscitation, and critical care. The market spans endotracheal tubes, laryngeal mask airways, tracheostomy tubes, video laryngoscopes, bronchoscopes, supraglottic airway devices, resuscitators, and supporting accessories used across operating rooms, emergency departments, intensive care units, ambulatory surgery centers, and prehospital care.

Demand is supported by measurable healthcare fundamentals, including rising surgical volumes, expanding intensive care capacity, aging populations with higher cardiopulmonary risk, emergency medicine preparedness, and continued adherence to difficult-airway guidelines from professional bodies such as the American Society of Anesthesiologists and the Difficult Airway Society. Buyers increasingly prioritize devices that improve first-pass success, reduce airway trauma, support infection prevention, and integrate into digitally enabled clinical workflows.

Transformative Shifts in the Airway Management Landscape

The airway management devices landscape is shifting from basic airway access tools toward connected, visualization-enabled, and protocol-driven solutions. Video laryngoscopy has moved from specialty use into mainstream anesthesia, emergency, and critical care practice because real-time visualization supports clinician training, team communication, and difficult-airway management. Single-use bronchoscopes and disposable airway accessories are also gaining relevance as hospitals align purchasing with infection-control policies and sterilization capacity constraints.

Another major transformation is the movement of airway care beyond traditional operating rooms. Growth in ambulatory surgery, emergency medical services, home ventilation support, and transport medicine is increasing the need for compact, rugged, easy-to-use devices. At the same time, manufacturers are responding to hospital value-analysis committees by emphasizing clinical evidence, total cost of ownership, supply resilience, and compatibility with established airway algorithms.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is beginning to reshape airway management by improving training, planning, workflow efficiency, and device performance monitoring. In simulation environments, AI-enabled feedback can help clinicians refine intubation technique, recognize airway anatomy, and reduce variability in procedural learning. In connected video platforms, computer vision may support image quality optimization, anatomy recognition, documentation, and future decision support, although clinical validation, regulatory oversight, and human supervision remain essential.

AI also has operational value for hospitals and manufacturers. Predictive analytics can support inventory planning for endotracheal tubes, supraglottic airways, and single-use scopes, while service analytics can help reduce downtime for reusable visualization systems. The cumulative impact is strongest where AI complements, rather than replaces, clinician judgment, improves first-pass success metrics, supports compliance documentation, and aligns with patient-safety governance.

Key Regional Insights

Asia-Pacific is one of the most dynamic regions for airway management devices due to expanding hospital infrastructure, growing surgical capacity, and rising investment in emergency and critical care. China, India, Japan, South Korea, and Australia show strong demand patterns, with adoption shaped by public hospital procurement, private specialty care expansion, aging demographics, and local manufacturing capabilities. North America remains a high-value region supported by advanced anesthesia standards, strong penetration of video laryngoscopy, robust emergency medical services, intensive care preparedness, and established reimbursement and purchasing structures.

Europe is characterized by guideline-led airway practice, mature hospital procurement, and strong emphasis on device safety, traceability, and environmental considerations under evolving medical device regulation. Latin America is advancing through modernization of operating rooms and critical care units, with Brazil and Mexico serving as important demand centers. The Middle East is investing in hospital capacity, medical tourism, trauma care, and tertiary specialty services, particularly in GCC countries, while Africa presents long-term opportunity tied to surgical access initiatives, emergency care development, clinician training, and affordable airway solutions suitable for resource-variable settings.

Key Group Insights

ASEAN demand is supported by medical tourism, hospital network expansion, and increasing investment in anesthesia and emergency care capabilities across markets such as Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines. GCC countries are accelerating adoption of advanced airway management devices as national healthcare strategies prioritize tertiary hospitals, trauma systems, emergency preparedness, and internationally accredited care. The European Union remains influential through regulatory harmonization under the EU Medical Device Regulation, which places high importance on clinical evidence, post-market surveillance, unique device identification, and device traceability.

BRICS countries represent a broad growth platform because of large patient populations, expanding surgical access, strengthening critical care capacity, and stronger domestic medtech production, although procurement models and price sensitivity vary widely. G7 markets remain vendors in premium airway visualization, evidence-based procurement, infection-prevention protocols, and clinical training infrastructure. NATO member countries add demand from military medicine, emergency preparedness, field hospitals, and transport ventilation, where device durability, interoperability, portability, and rapid deployment are critical purchasing factors.

Key Country Insights

The United States leads in advanced airway management adoption due to high surgical throughput, strong emergency medical systems, widespread clinician training, and extensive use of video laryngoscopy in hospitals and education programs. Canada emphasizes standardized clinical practice, public procurement, and equitable access across regional health systems, while Mexico and Brazil show rising demand as private hospitals and public systems modernize anesthesia, emergency medicine, and intensive care capabilities. In Europe, the United Kingdom, Germany, France, Italy, and Spain demonstrate mature demand supported by clinical guidelines, aging demographics, established operating room infrastructure, and structured hospital purchasing, while Russia maintains demand across urban tertiary centers, emergency care networks, and critical care facilities.

China and India are pivotal growth markets because of large procedure volumes, expanding hospital capacity, increasing domestic device production, and broader access to surgical and critical care services. Japan prioritizes high-quality, precision-oriented technologies aligned with an aging population and advanced hospital systems. Australia shows steady demand through mature anesthesia practice, regional emergency care needs, and transport medicine requirements, while South Korea combines sophisticated hospital infrastructure with strong medtech innovation, supporting adoption of advanced visualization, endotracheal intubation tools, and airway access solutions.

Actionable Recommendations for Industry Leaders

Industry vendors should prioritize clinically validated differentiation. Products that demonstrate improved first-pass success, reduced complications, faster workflow, easier training, and infection-control advantages are better positioned with hospital value-analysis committees. Manufacturers should invest in ergonomic design, adult and pediatric portfolio breadth, single-use and reusable options, sustainable material strategies, and interoperability with digital documentation systems.

Commercial teams should tailor strategies by care setting and region. Premium visualization platforms may fit tertiary hospitals and academic centers, while cost-effective supraglottic devices, endotracheal tubes, and portable resuscitation tools are critical for emerging markets and prehospital care. Vendors should also strengthen supply-chain resilience, maintain regulatory readiness, expand clinician education programs, support difficult-airway protocol adoption, and build evidence packages that connect device performance to measurable patient-safety outcomes.

Research Methodology

A rigorous airway management devices assessment should combine secondary research, primary interviews, regulatory review, and demand-side validation. Reliable secondary inputs include public health datasets, hospital procedure trends, professional society guidelines, regulatory databases, procurement notices, peer-reviewed clinical literature, adverse event reporting systems, and trade data. Primary research should include anesthesiologists, intensivists, emergency physicians, respiratory therapists, procurement firms, distributors, biomedical engineers, and device manufacturers.

Evidence should be triangulated across procedure volumes, installed base analysis, product replacement cycles, pricing bands, import-export flows, regulatory approvals, and regional purchasing patterns. Competitive assessment should evaluate device portfolios, regulatory clearances, clinical evidence, channel strength, manufacturing footprint, training support, supply reliability, and post-market surveillance. This methodology supports defensible insights while reducing overreliance on unverified claims or single-source assumptions.

Conclusion

The airway management devices market is becoming more technology-enabled, evidence-driven, and geographically diversified. Hospitals and emergency care providers are moving toward solutions that improve visualization, speed, safety, infection prevention, and procedural consistency across routine, emergency, pediatric, and difficult-airway scenarios.

Future industry performance will depend on the ability of manufacturers to combine clinical utility with affordability, regulatory compliance, training support, and reliable supply. Organizations that align innovation with real-world workflow needs, validated patient-safety outcomes, and region-specific procurement expectations will be best positioned to capture demand across mature and emerging healthcare systems.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Airway Management Devices Market, by Product Type

• 7.1. Endobronchial Tubes
• 7.2. Endotracheal Tubes
  • 7.2.1. Cuffed
  • 7.2.2. Uncuffed
• 7.3. Intubation Stylets
• 7.4. Laryngeal Mask Airways
• 7.5. Laryngoscopes

8. Airway Management Devices Market, by Material

• 8.1. Polyvinyl Chloride
• 8.2. Silicone

9. Airway Management Devices Market, by Insertion Technique

• 9.1. Direct Laryngoscopy
• 9.2. Video Laryngoscopy

10. Airway Management Devices Market, by End User

• 10.1. Ambulatory Surgical Centers
• 10.2. Emergency Medical Services
• 10.3. Home Care Settings
• 10.4. Hospitals

11. Airway Management Devices Market, by Application

• 11.1. Emergency Care
• 11.2. Home Care
• 11.3. Intensive Care
• 11.4. Operating Room
• 11.5. Pre Hospital

12. Airway Management Devices Market, by Size

• 12.1. Adult
• 12.2. Neonatal
• 12.3. Pediatric

13. Airway Management Devices Market, by Region

• 13.1. Asia-Pacific
• 13.2. North America
• 13.3. Latin America
• 13.4. Europe
• 13.5. Middle East
• 13.6. Africa

14. Airway Management Devices Market, by Group

• 14.1. ASEAN
• 14.2. GCC
• 14.3. European Union
• 14.4. BRICS
• 14.5. G7
• 14.6. NATO

15. Airway Management Devices Market, by Country

• 15.1. United States
• 15.2. Canada
• 15.3. Mexico
• 15.4. Brazil
• 15.5. United Kingdom
• 15.6. Germany
• 15.7. France
• 15.8. Russia
• 15.9. Italy
• 15.10. Spain
• 15.11. China
• 15.12. India
• 15.13. Japan
• 15.14. Australia
• 15.15. South Korea

16. Competitive Landscape

• 16.1. Market Concentration Analysis, 2025
  • 16.1.1. Concentration Ratio (CR)
  • 16.1.2. Herfindahl Hirschman Index (HHI)
• 16.2. Recent Developments & Impact Analysis, 2025
• 16.3. Product Portfolio Analysis, 2025
• 16.4. Benchmarking Analysis, 2025

17. Company Profiles

• 17.1. Ambu A/S
• 17.2. Armstrong Medical Limited
• 17.3. Atos Medical AB
• 17.4. Becton, Dickinson and Company
• 17.5. Bell Medical Inc.
• 17.6. BOMImed, Inc.
• 17.7. Convatec Inc.
• 17.8. Cook Group Incorporated
• 17.9. Fisher & Paykel Healthcare Limited
• 17.10. Flexicare (Group) Limited
• 17.11. Intersurgical Ltd.
• 17.12. Karl Storz SE & Co. KG
• 17.13. Medcaptain Medical Technology Co. Ltd.
• 17.14. Medis Medical (UK) Ltd
• 17.15. Medtronic PLC
• 17.16. Mercury Enterprises, Inc.
• 17.17. Novatech SA
• 17.18. Olympus Corporation
• 17.19. P3 Medical Ltd.
• 17.20. QuadMed, Inc
• 17.21. Smiths Medical, Inc. by ICU Medical, Inc.
• 17.22. SourceMark Medical
• 17.23. SunMed
• 17.24. Teleflex Incornorated
• 17.25. VBM Medizintechnik GmbH
• 17.26. Verathon Inc by Roper Technologies
• 17.27. Viggo Medical Devices
• 17.28. Wittenburg Group